Table 2.
The effect of M. myristica of the levels of liver marker enzyme activities
| Treatment group | ALP activity (U/L) | ALT activity (U/L) | AST activity (U/L) |
|---|---|---|---|
| G1 | 110.37 ± 0.75b | 115.61 ± 1.21b | 121.25 ± 3.78a,c |
| G2 | 149.89 ± 0.44a | 156.50 ± 1.80a | 181.17 ± 5.20b |
| G3 | 120.04 ± 0.19 | 139.01 ± 3.79 | 169.82 ± 3.43a |
| G4 | 109.59 ± 0.61 | 104.12 ± 2.63 | 136.20 ± 1.57 |
| G5 | 98.62 ± 0.32a,b | 108.27 ± 0.13 | 127.27 ± 0.17 |
Values shown are mean ± SD (n = 6). Mean differences are significant (P < 0.05) when compared with: aG1 (control group), b G2 (cadmium only)